Related Experiment Video
Updated: Oct 5, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Metabolic complications of HIV-1 antiretroviral therapy: the lipodystrophy syndrome
M Borderi1, G Verucchi, M Tadolini
1Department of Clinical and Experimental Medicine, Section of Infectious Diseases, University of Bologna, Massarenti, Italy.
Abstract:
The lipodystrophy syndrome is one of the complications reported with increased frequency in patients with HIV-1 infection receiving antiretroviral therapy. The wide range of prevalence estimates may be due to differing definitions, methods and patient populations. We described the various pathogenic theories and the morphological and metabolic alterations associated with this syndrome. Even if no effective treatment exists, a correct lifestyle, adequate diet and physical exercise seem to be very important. Moreover drug therapies should be used with care to avoid potentially harmful interactions with antiretroviral agents. Ideally, the future effort to define the mechanism of lipodystrophy would be multidisciplinary and would involve not only experts in AIDS research but also nutritionists, endocrinologists and cardiologists.
Related Concept Videos
Retrovirus Life Cycles
Complications of Diabetes Mellitus
Type I Diabetes III: Clinical Manifestations
Type II Diabetes II: Pathophysiology
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Diabetes: Symptoms, Diagnosis, and Complications

